Aronia berries are a native North American berry with high naturally occurring anthocyanins among other polyphenols. Based on their polyphenol composition, there is growing interest in the potential for Aronia berries to elicit health promoting cardio-metabolic effects. Specifically, Aronia berry extracts, which provide a concentrated source of polyphenols, may improve blood vessel function. Thus, the primary focus of this project is to evaluate the effects of Aronia berry polyphenols on blood pressure and other biomarkers of cardiovascular disease risk such as endothelial function, arterial stiffness and blood lipids.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
102
Identical formulation as the treatment consisting of colored maltodextrin using artificial colors.
Powdered extract obtained from aronia berries (Aronia melanocarpa).
Department of Life Sciences and Medecine
London, Central London, United Kingdom
King's College London
London, England, United Kingdom
Changes from baseline ambulatory blood pressure after 12-week consumption
Determine the effect of the Aronia extract vs Placebo on ambulatory 24-hour systolic and diastolic blood pressure at 12 weeks post consumption, compared to the baseline.
Time frame: Baseline and 12 weeks
Office blood pressure
Determine the effect of the Aronia extract vs Placebo on office systolic and diastolic blood pressure, at 12 weeks post consumption
Time frame: Baseline 0 and 2 hours and 12 weeks 0 and 2 hours
Heart rate
Determine the effect of the Aronia extract vs Placebo on heart rate, at 12 weeks post consumption
Time frame: Baseline 0 and 2 hours and 12 weeks 0 and 2 hours
Flow-mediated dilation
Determine the effect of the Aronia extract vs Placebo on flow-mediated dilation at 12 weeks post consumption
Time frame: Baseline 0 and 2 hours and 12 weeks 0 and 2 hours
Blood flow velocity
Determine the effect of the Aronia extract vs Placebo on blood flow velocity at 12 weeks post consumption
Time frame: Baseline 0 and 2 hours and 12 weeks 0 and 2 hours
Pulse wave velocity (PWV)
Determine the effect of the Aronia extract vs Placebo on pulse wave velocity (PWV) using a Sphygmocor device, at 12 weeks post consumption
Time frame: Baseline 0 and 2 hours and 12 weeks 0 and 2 hours
Augmentation Index (AIx)
Determine the effect of the Aronia extract vs Placebo on augmentation Index (AIx) using a Sphygmocor device, at 12 weeks post consumption
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline 0 and 2 hours and 12 weeks 0 and 2 hours
Blood lipids
Determine the effect of the Aronia extract vs Placebo on blood lipids (Total, HDL and LDL cholesterol, triglycerides), at 12 weeks post consumption
Time frame: Baseline and 12 weeks
Blood cortisol
Determine the effect of the Aronia extract vs Placebo on blood cortisol levels, at 12 weeks post consumption
Time frame: Baseline and 12 weeks
Number of volunteers with treatment-related adverse events
The number of volunteers with treatment-related adverse events will be assessed by questionnaires and interviews.
Time frame: Baseline and 12 weeks
24-hour heart rate
Determine the effect of the Aronia extract vs Placebo on 24-hour heart rate, using a monitor, at 12 weeks post consumption
Time frame: Baseline and 12 weeks